For patients with operable non-small cell lung cancer (NSCLC), pre-surgical "neoadjuvant" treatment with an immune checkpoint inhibitor was well tolerated and, in many cases, caused significant tumor cell death in a large.
from Medindia Health News http://bit.ly/2MnaLxG
No comments:
Post a Comment